These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20382269)

  • 1. Pacemaker/implantable cardioverter-defibrillator interaction.
    Jimenez A; Dickfeld T; Saliaris A; Shorofsky S
    Heart Rhythm; 2010 Aug; 7(8):1157-60. PubMed ID: 20382269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized-controlled trial of ventricular fibrillation detection time in a DDDR ventricular defibrillator. Ventak AV II DR Study Investigators.
    Ellenbogen KA; Edel T; Moore S; Higgins S; Pacifico A; Wilber D; Wood MA; Rogers R; Dahn A; Zhu A
    Pacing Clin Electrophysiol; 2000 Aug; 23(8):1268-72. PubMed ID: 10962750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The concurrent implantation of a last-generation automatic defibrillator and a 2-chamber pacemaker].
    Cesario AS; Palermo P; Baragli D; Amici E; Biancalana G; Gambelli G; Neri R
    G Ital Cardiol; 1998 Aug; 28(8):878-86. PubMed ID: 9773313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.
    Nakao Y; Suenari K; Yamashiro K; Nakagawa H; Shiode N
    BMC Cardiovasc Disord; 2020 Mar; 20(1):134. PubMed ID: 32169057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undersensing of ventricular fibrillation due to interference between a pacemaker and defibrillator in the same patient.
    Van Casteren L; Huybrechts W; Willems R
    Europace; 2009 Oct; 11(10):1390-1. PubMed ID: 19654130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable intravascular defibrillator: defibrillation thresholds of an intravascular cardioverter-defibrillator compared with those of a conventional ICD in humans.
    Neuzil P; Reddy VY; Merkely B; Geller L; Molnar L; Bednarek J; Bartus K; Richey M; Bsee TJ; Sanders WE
    Heart Rhythm; 2014 Feb; 11(2):210-5. PubMed ID: 24144885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stepwise testing protocol for modern implantable cardioverter-defibrillator systems to prevent pacemaker-implantable cardioverter-defibrillator interactions.
    Glikson M; Trusty JM; Grice SK; Hayes DL; Hammill SC; Stanton MS
    Am J Cardiol; 1999 Feb; 83(3):360-6. PubMed ID: 10072224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with an implantable cardioverter defibrillator for spontaneous ventricular fibrillation in dilated cardiomyopathy with very high defibrillation thresholds.
    Tamura K; Abe H; Nagatomo T; Nakashima Y
    J UOEH; 2001 Dec; 23(4):363-8. PubMed ID: 11789138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implantable cardioverter defibrillator: technology, indications, and impact on cardiovascular survival.
    Bhatia A; Cooley R; Berger M; Blanck Z; Dhala A; Sra J; Axtell-Mcbride K; Vandervort C; Akhtar M
    Curr Probl Cardiol; 2004 Jun; 29(6):303-56. PubMed ID: 15159713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications for dual-chamber (DDD) pacing in implantable cardioverter-defibrillator patients.
    Santini M; Ansalone G; Auriti A; Magris B; Pandozi C; Altamura G
    Am J Cardiol; 1996 Sep; 78(5A):116-8. PubMed ID: 8820847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators.
    Best PJ; Hayes DL; Stanton MS
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):79-85. PubMed ID: 9990604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled clinical trial comparing ventricular fibrillation detection time between two transvenous defibrillator models. The Acute Ventak AV investigator group.
    Kühlkamp V; Mortensen P; Kirstein P; den Dulk K; Hoffman E; Wilber D; Higgins S; Kühl M
    Pacing Clin Electrophysiol; 1999 Jul; 22(7):990-8. PubMed ID: 10456626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance.
    Tjong FV; Brouwer TF; Smeding L; Kooiman KM; de Groot JR; Ligon D; Sanghera R; Schalij MJ; Wilde AA; Knops RE
    Europace; 2016 Nov; 18(11):1740-1747. PubMed ID: 26941338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fully automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to T-wave oversensing in spontaneous rhythm.
    Cao J; Gillberg JM; Swerdlow CD
    Heart Rhythm; 2012 Apr; 9(4):522-30. PubMed ID: 22094074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.